İrEm Unat
Research Subjects
İrEm Unat has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Tuğrul Hoşbul
Department of Medical Microbiology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye
2 shared publications - Canset Nur Aydogan
Department of Medical Microbiology, Ordu State Hospital, Ordu, Turkey
1 shared publication - Cumhur Artuk
Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
1 shared publication - Fatih Şahiner
Division of Medical Virology, Department of Medical Microbiology, Gulhane Military Medical Academy, Ankara, Turkey
1 shared publication - Gamze Icen
Department of Internal Medicine, Cukurova State Hospital, Adana, Turkey
1 shared publication - Mehmet Tevfik Yavuz
Department of Medical Microbiology, University of Health Sciences Gülhane School of Medicine, Ankara, Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (09) , 1351-1360
Evaluation of biofilm activity, virulence genes, and antibiotic susceptibility profiles in clinical Proteus mirabilis isolates
Introduction: Proteus mirabilis is a common opportunistic pathogen in wound and urinary tract infections (UTIs), whose clinical significance is driven by biofilm formation. This virulence-mediated process provides a shield against antimicrobials and host immunity, promoting difficult-to-treat infections. This study aimed to elucidate the relationship between biofilm-forming capacity, presence of virulence genes, and antibiotic resistance profiles in P. mirabilis isolates. Methodology: A total of 76 P. mirabilis isolates from urine and wound samples were analyzed. Isolates were identified using MALDI-TOF MS, antimicrobial susceptibility was tested via VITEK®2, biofilm formation was measured using the crystal violet method, and the presence of virulence genes (ureC, ireA, zapA, rsbA, flaA, atfA, ucaA, and hpmA) was analyzed by PCR. Results: Wound isolates showed significantly enhanced biofilm production and higher resistance rates to multiple antibiotics. Moderate-to-strong biofilm production was significantly associated with catheterization, the presence of the zapA, atfA, and ucaA genes, and increased resistance to ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SXT). The presence of the hpmA gene showed a borderline association with TMP-SXT resistance. The presence of the rsbA gene was significantly associated with a reduced likelihood of ertapenem resistance, suggesting a role in modulating porin-mediated antibiotic uptake. Conclusions: Biofilm-mediated resistance is a significant barrier to managing P. mirabilis infections, particularly in wounds and catheter-associated UTIs. The presence of specific genes in moderate-to-strong biofilm producers indicates their products are integral to the structural integrity and the functional capacity of the biofilm. The inverse relationship between rsbA and carbapenem resistance warrants further investigation as a biomarker for susceptibility.
- 30 September 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (09) , 1351-1360
Open AccessEvaluation of biofilm activity, virulence genes, and antibiotic susceptibility profiles in clinical Proteus mirabilis isolates
Introduction: Proteus mirabilis is a common opportunistic pathogen in wound and urinary tract infections (UTIs), whose clinical significance is driven by biofilm formation. This virulence-mediated process provides a shield against antimicrobials and host immunity, promoting difficult-to-treat infections. This study aimed to elucidate the relationship between biofilm-forming capacity, presence of virulence genes, and antibiotic resistance profiles in P. mirabilis isolates. Methodology: A total of 76 P. mirabilis isolates from urine and wound samples were analyzed. Isolates were identified using MALDI-TOF MS, antimicrobial susceptibility was tested via VITEK®2, biofilm formation was measured using the crystal violet method, and the presence of virulence genes (ureC, ireA, zapA, rsbA, flaA, atfA, ucaA, and hpmA) was analyzed by PCR. Results: Wound isolates showed significantly enhanced biofilm production and higher resistance rates to multiple antibiotics. Moderate-to-strong biofilm production was significantly associated with catheterization, the presence of the zapA, atfA, and ucaA genes, and increased resistance to ciprofloxacin and trimethoprim-sulfamethoxazole (TMP-SXT). The presence of the hpmA gene showed a borderline association with TMP-SXT resistance. The presence of the rsbA gene was significantly associated with a reduced likelihood of ertapenem resistance, suggesting a role in modulating porin-mediated antibiotic uptake. Conclusions: Biofilm-mediated resistance is a significant barrier to managing P. mirabilis infections, particularly in wounds and catheter-associated UTIs. The presence of specific genes in moderate-to-strong biofilm producers indicates their products are integral to the structural integrity and the functional capacity of the biofilm. The inverse relationship between rsbA and carbapenem resistance warrants further investigation as a biomarker for susceptibility.
- Open Access
- 17 August 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (7)
Analysis of Immune Profiles Related to Disease Severity in COVID-19 by Flow Cytometry
Background: More than 768 million people have been affected by COVID-19. Identifying lymphocyte subsets and cytokine level abnormalities in COVID-19 patients is essential to gain new insights and data on immunity mechanisms against viral infections. Objectives: We used flow cytometry to determine the relationship between disease severity, lymphocyte subsets distribution, and cytokine level alterations in COVID-19 patients. Methods: Totally 94 COVID-19 patients (32 mild, 31 moderate, and 31 severe) and 27 healthy individuals were included in the cross-sectional study. The distribution of peripheral lymphocyte subsets and cytokine levels was assessed by flow cytometry. Results: The percentages of CD56+ natural killer (NK) cells in all patient groups and total T lymphocytes in moderate and severe groups were significantly lower than those in the control group (P < 0.001). Also, IL-2 (P < 0.001), IL-17A (P < 0.001), IL-4 (P < 0.001), IL-6 (P < 0.001), TNF-α (P = 0.004), IP-10 (P < 0.001), IFN-λ1 (IL-29) (P < 0.001), IFN-λ2/3 (IL-28A/B) (P = 0.011), IFN-β (P < 0.001), IL-10 (P < 0.001), and IFN-γ (P < 0.001) levels were statistically higher in patients than in the controls. Conclusions: Our data revealed that increased levels of certain cytokines in peripheral blood contribute to disease severity. Increased CRP (OR: 1.012, %95 CI: 1.002 - 1.023, P = 0.038) and IL-10 (OR: 1.068, %95 CI: 1.000 - 1.141, P = 0.049) levels, decreased CD56+ NK percentage (OR: 0.576, %95 CI: 0.376 - 0.882, P = 0.011) and lymphocyte count (OR: 0.02, %95 CI: 0.001 - 0.368, P = 0.009), and the presence of diabetes mellitus and mechanical ventilation were independent predictors of mortality.
- 17 August 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (7)
Open AccessAnalysis of Immune Profiles Related to Disease Severity in COVID-19 by Flow Cytometry
Background: More than 768 million people have been affected by COVID-19. Identifying lymphocyte subsets and cytokine level abnormalities in COVID-19 patients is essential to gain new insights and data on immunity mechanisms against viral infections. Objectives: We used flow cytometry to determine the relationship between disease severity, lymphocyte subsets distribution, and cytokine level alterations in COVID-19 patients. Methods: Totally 94 COVID-19 patients (32 mild, 31 moderate, and 31 severe) and 27 healthy individuals were included in the cross-sectional study. The distribution of peripheral lymphocyte subsets and cytokine levels was assessed by flow cytometry. Results: The percentages of CD56+ natural killer (NK) cells in all patient groups and total T lymphocytes in moderate and severe groups were significantly lower than those in the control group (P < 0.001). Also, IL-2 (P < 0.001), IL-17A (P < 0.001), IL-4 (P < 0.001), IL-6 (P < 0.001), TNF-α (P = 0.004), IP-10 (P < 0.001), IFN-λ1 (IL-29) (P < 0.001), IFN-λ2/3 (IL-28A/B) (P = 0.011), IFN-β (P < 0.001), IL-10 (P < 0.001), and IFN-γ (P < 0.001) levels were statistically higher in patients than in the controls. Conclusions: Our data revealed that increased levels of certain cytokines in peripheral blood contribute to disease severity. Increased CRP (OR: 1.012, %95 CI: 1.002 - 1.023, P = 0.038) and IL-10 (OR: 1.068, %95 CI: 1.000 - 1.141, P = 0.049) levels, decreased CD56+ NK percentage (OR: 0.576, %95 CI: 0.376 - 0.882, P = 0.011) and lymphocyte count (OR: 0.02, %95 CI: 0.001 - 0.368, P = 0.009), and the presence of diabetes mellitus and mechanical ventilation were independent predictors of mortality.
- 7 December 2022
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
Different Types and Modifications of Polymerase Chain Reaction
In this study, it is aimed to provide an up-to-date overview of different types and application areas of polymerase chain reaction (PCR) developed with technological advances. PCR has accelerated scientific studies with its use in medical research and molecular biology. PCR based methods are used in many fields such as diagnosis of infectious diseases, microorganism typing, gene expression analysis, epidemiology and taxonomy fields, oncological studies, DNA cloning, analysis of point mutations, insertion of transposon elements, polymorphism studies, population typing, phylogenetic analysis, drug level analysis, and autoantibody detection. Multiplex PCR is used for simultaneous amplification of multiple targets using multiple primer pairs, consensus PCR is used for amplification of common (conserved) gene regions of genetically related microorganisms, rep-PCR is used for amplification of repetitive fingerprint DNA sequences in microbial genomes, nested PCR is used to reduce non-specific primer binding and increase sensitivity, hot start PCR is used to reduce the presence of non-specific products and primer dimers, anchored PCR is used to enable amplification of unknown gene regions using non-specific anchor primers, ligation mediated and homopolymer PCR is used for amplification of a DNA segment with a single known primer binding site, touch-down and touch-up PCR is used to prevent mismatches by regulating annealing temperature, autosticky PCR is used for amplification of DNA fragments for gene cloning using abasic primers, methylation specific PCR is used to determine the methylation patterns of cytosine residues, inverse PCR is used for sequence analysis of unknown flanking DNA regions, asymmetric PCR is used to synthesize single-stranded DNA using primers of different concentrations, in-situ PCR is used to visualize intracellular amplification in tissue sections, RAPD is used for amplifying random DNA segments using random primers and for population analysis, immuno-PCR is used for detection of low concentration amplicons by combining ELISA and PCR methods, real-time PCR is used for quantitation and monitoring of amplification with real time fluorescent signals, digital PCR is used for absolute quantitative amplification, long-range PCR for amplification of long target DNA regions, and reverse transcription PCR is used to provide amplification by synthesizing cDNA from RNA with reverse transcriptase enzyme. PCR modifications have developed rapidly throughout history. Having knowledge about these modifications will be an eye-opener for new methods to be discovered with technological developments, will contribute to selection of appropriate methods, and will increase the sensitivity and specificity of the reactions.
- 7 December 2022
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
Different Types and Modifications of Polymerase Chain Reaction
In this study, it is aimed to provide an up-to-date overview of different types and application areas of polymerase chain reaction (PCR) developed with technological advances. PCR has accelerated scientific studies with its use in medical research and molecular biology. PCR based methods are used in many fields such as diagnosis of infectious diseases, microorganism typing, gene expression analysis, epidemiology and taxonomy fields, oncological studies, DNA cloning, analysis of point mutations, insertion of transposon elements, polymorphism studies, population typing, phylogenetic analysis, drug level analysis, and autoantibody detection. Multiplex PCR is used for simultaneous amplification of multiple targets using multiple primer pairs, consensus PCR is used for amplification of common (conserved) gene regions of genetically related microorganisms, rep-PCR is used for amplification of repetitive fingerprint DNA sequences in microbial genomes, nested PCR is used to reduce non-specific primer binding and increase sensitivity, hot start PCR is used to reduce the presence of non-specific products and primer dimers, anchored PCR is used to enable amplification of unknown gene regions using non-specific anchor primers, ligation mediated and homopolymer PCR is used for amplification of a DNA segment with a single known primer binding site, touch-down and touch-up PCR is used to prevent mismatches by regulating annealing temperature, autosticky PCR is used for amplification of DNA fragments for gene cloning using abasic primers, methylation specific PCR is used to determine the methylation patterns of cytosine residues, inverse PCR is used for sequence analysis of unknown flanking DNA regions, asymmetric PCR is used to synthesize single-stranded DNA using primers of different concentrations, in-situ PCR is used to visualize intracellular amplification in tissue sections, RAPD is used for amplifying random DNA segments using random primers and for population analysis, immuno-PCR is used for detection of low concentration amplicons by combining ELISA and PCR methods, real-time PCR is used for quantitation and monitoring of amplification with real time fluorescent signals, digital PCR is used for absolute quantitative amplification, long-range PCR for amplification of long target DNA regions, and reverse transcription PCR is used to provide amplification by synthesizing cDNA from RNA with reverse transcriptase enzyme. PCR modifications have developed rapidly throughout history. Having knowledge about these modifications will be an eye-opener for new methods to be discovered with technological developments, will contribute to selection of appropriate methods, and will increase the sensitivity and specificity of the reactions.